Selexis CHO Cells in Suspension-1

Latest News

Selexis has been setting the pace of innovation in protein expression and establishing new benchmarks in bioproduction for  two decades.

JULY 6, 2022
3 min read

KBI Biopharma and Selexis Hold Joint Ribbon Cutting of the Expanded State-of-the-Art Facility in Geneva, Switzerland

The KBI and Selexis co-location will expand biopharmaceutical development and manufacturing capabilities to serve the...

Read More
MAY 11, 2022
4 min read

Great Place to Work® Designates Selexis as a Best Workplace in Switzerland for Fifth Straight Year

Geneva, Switzerland, May 11, 2022Selexis SA, a JSR Life Sciences Company, announced today that Great Place to Work®...

Read More
MAY 2, 2022
7 min read

JSR Appoints Veteran Biotech and CDMO Leader Mark W. Womack to Lead KBI Biopharma and Selexis SA

SUNNYVALE, California, May 2, 2022 – JSR Life Sciences, LLC (JSR) today announced that Mark W. Womack will serve as...

Read More